AP-1/jun binding sites mediate serum inducibility of the human vimentin promoter
Open accessThe DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
The vimentin gene is inducible by serum in quiescent Balb/c 3T3 cells, but the molecular mechanism of this induction is unknown. The results presented here represent a first step towards the elucidation of the pathway of events leading from growth factor-receptor interaction to this induction. A series of Bal 31 deletions of the human vimentin promoter are used to show that a sequence residing at -700 is responsible for the serum, and also TPA inducibility of this gene. This sequence is able to confer serum inducibility upon uninducible constructs regardless of its position and orientation, indicating that it is this element alone which is required for this induction. The isolated sequence is a strong enhancer as well. Further deletions and the use of synthetic oligonucleotides demonstrate that a 24-mer containing two AP-1/jun binding sites confer both serum and TPA inducibility upon the human vimentin gene. Gel retardation analysis confirms that this sequence binds an AP-1 -like protein.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Purification and biochemical characterization of the promoter-specific transcription factor, Sp1
Briggs, M. R., Kadonaga, J. T., Bell, S. P., & Tjian, R. (1986) · Science · doi:10.1126/science.3529394 · Cited by 1,435
Bohmann, D., Bos, T. J., Admon, A., Nishimura, T., Vogt, P. K., & Tjian, R. (1987) · Science · doi:10.1126/science.2825349 · Cited by 1,321
Oncogene jun encodes a sequence-specific trans- activator similar to AP-1
Angel, P., Allegretto, E. A., Okino, S. T., Hattori, K., Boyle, W. J., Hunter, T., & Karin, M. (1988) · Nature · doi:10.1038/332166a0 · Cited by 907
Cited by
Vimentin in cancer and its potential as a molecular target for cancer therapy
Satelli, A., & Li, S. (2011) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-011-0735-1 · Cited by 1,557
Vimentin Is at the Heart of Epithelial Mesenchymal Transition (EMT) Mediated Metastasis
Usman, S., Waseem, N. H., Nguyen, T. K. N., Mohsin, S., Jamal, A., Teh, M.-T., & Waseem, A. (2021) · Cancers · doi:10.3390/cancers13194985 · Cited by 430
The Role of Vimentin Intermediate Filaments in the Progression of Lung Cancer
Kidd, M. E., Shumaker, D. K., & Ridge, K. M. (2014) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2013-0314tr · Cited by 330
Vimentin contributes to human mammary epithelial cell migration
Gilles, C., Polette, M., Zahm, J.-M., Tournier, J.-M., Volders, L., Foidart, J.-M., & Birembaut, P. (1999) · Journal of Cell Science · doi:10.1242/jcs.112.24.4615 · Cited by 314
Lesion-induced increase in nerve growth factor mRNA is mediated by c-fos.
Hengerer, B., Lindholm, D., Heumann, R., Rüther, U., Wagner, E. F., & Thoenen, H. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.10.3899 · Cited by 312
Vogt, P. K. (2001) · Oncogene · doi:10.1038/sj.onc.1204443 · Cited by 289
Vimentin on the move: new developments in cell migration
Battaglia, R. A., Delic, S., Herrmann, H., & Snider, N. T. (2018) · F1000Research · doi:10.12688/f1000research.15967.1 · Cited by 274
Vimentin Intermediate Filaments as Potential Target for Cancer Treatment
Strouhalova, K., Přechová, M., Gandalovičová, A., Brábek, J., Gregor, M., & Rosel, D. (2020) · Cancers · doi:10.3390/cancers12010184 · Cited by 255
(1994) · PubMed · Cited by 53
Hass, R., Brach, M., Kharbanda, S., Giese, G., Traub, P., & Kufe, D. (1991) · Journal of Cellular Physiology · doi:10.1002/jcp.1041490116 · Cited by 31
(2000) · doi:10.1002/1097-0215(20001015)88:2<157::aid-ijc2>3.0.co;2-b
Metadata
- Authors
- Rittling, S. R., Coutinho, L., Amram, T., & Kolbe, M.
- Venue
- Nucleic Acids Research
- Publisher
- Oxford University Press (OUP)
- Published
- 1989
- Volume
- 17
- Issue
- 4
- Pages
- 1619-1633
- ISSN
- 0305-1048 (ISSN-L)
- 1362-4962
- OpenAlex
- W2086058155
- Cited by
- 83
- References
- 3
- FWCI
- 2.11
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.